| endocrine pancreas development | GO:0031018 | 29 | 0.975 | |
| transdifferentiation | GO:0060290 | 1 | 0.961 | |
| pancreatic pp cell fate commitment | GO:0003329 | 2 | 0.952 | |
| glucose homeostasis | GO:0042593 | 128 | 0.942 | |
| connective tissue development | GO:0061448 | 179 | 0.937 | |
| endocrine system development | GO:0035270 | 98 | 0.929 | |
| regulation of system process | GO:0044057 | 200 | 0.929 | |
| pancreatic pp cell differentiation | GO:0003312 | 2 | 0.926 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.922 | |
| pancreas development | GO:0031016 | 57 | 0.913 | |
| positive regulation of inner ear receptor cell differentiation | GO:2000982 | 1 | 0.901 | |
| pancreatic a cell fate commitment | GO:0003326 | 2 | 0.898 | |
| auditory receptor cell fate determination | GO:0042668 | 3 | 0.892 | |
| hexose metabolic process | GO:0019318 | 98 | 0.883 | |
| hemangioblast cell differentiation | GO:0060217 | 1 | 0.875 | |
| positive regulation of transcription from rna polymerase ii promoter involved in norepinephrine biosynthetic process | GO:2000763 | 1 | 0.851 | |
| regulation of intestinal epithelial structure maintenance | GO:0060730 | 1 | 0.848 | |
| regulation of peptide hormone secretion | GO:0090276 | 75 | 0.840 | |
| cell proliferation involved in outflow tract morphogenesis | GO:0061325 | 4 | 0.828 | |
| positive regulation of auditory receptor cell differentiation | GO:0045609 | 1 | 0.812 | |
| positive regulation of mechanoreceptor differentiation | GO:0045633 | 1 | 0.796 | |
| monosaccharide metabolic process | GO:0005996 | 106 | 0.788 | |
| cell fate determination | GO:0001709 | 32 | 0.773 | |
| cardiac neural crest cell migration involved in outflow tract morphogenesis | GO:0003253 | 3 | 0.770 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.760 | |
| regulation of mast cell differentiation | GO:0060375 | 3 | 0.744 | |
| regulation of hormone secretion | GO:0046883 | 88 | 0.741 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.741 | |
| developmental maturation | GO:0021700 | 193 | 0.735 | |
| semaphorin plexin signaling pathway involved in outflow tract morphogenesis | GO:0071527 | 1 | 0.730 | |
| extracellular matrix organization | GO:0030198 | 147 | 0.728 | |
| ventricular cardiac muscle tissue morphogenesis | GO:0055010 | 32 | 0.727 | |
| odontogenesis of dentin containing tooth | GO:0042475 | 66 | 0.708 | |
| regulation of transmembrane transport | GO:0034762 | 128 | 0.708 | |
| peptide hormone secretion | GO:0030072 | 109 | 0.699 | |
| regulation of cell migration | GO:0030334 | 219 | 0.699 | |
| tendon formation | GO:0035992 | 4 | 0.697 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.695 | |
| astrocyte fate commitment | GO:0060018 | 4 | 0.694 | |
| positive regulation of peptide hormone secretion | GO:0090277 | 31 | 0.693 | |
| regulation of cell motility | GO:2000145 | 236 | 0.685 | |
| endocardial cushion to mesenchymal transition involved in heart valve formation | GO:0003199 | 4 | 0.676 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.675 | |
| locomotory behavior | GO:0007626 | 195 | 0.669 | |
| ear development | GO:0043583 | 200 | 0.668 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.664 | |
| regulation of endocardial cushion to mesenchymal transition involved in heart valve formation | GO:2000800 | 1 | 0.661 | |
| cell fate commitment involved in pattern specification | GO:0060581 | 14 | 0.660 | |
| amide transport | GO:0042886 | 138 | 0.656 | |
| peptide secretion | GO:0002790 | 114 | 0.654 | |
| positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation | GO:2000802 | 1 | 0.652 | |
| prostate gland stromal morphogenesis | GO:0060741 | 2 | 0.648 | |
| negative regulation of type b pancreatic cell apoptotic process | GO:2000675 | 3 | 0.648 | |
| neuron migration | GO:0001764 | 122 | 0.641 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.639 | |
| ventral spinal cord interneuron fate commitment | GO:0060579 | 14 | 0.626 | |
| glandular epithelial cell differentiation | GO:0002067 | 38 | 0.620 | Human |
| cell proliferation involved in heart valve development | GO:2000793 | 2 | 0.619 | |
| cell differentiation in spinal cord | GO:0021515 | 53 | 0.617 | |
| regulation of auditory receptor cell differentiation | GO:0045607 | 4 | 0.615 | |
| spinal cord development | GO:0021510 | 81 | 0.611 | |
| positive regulation of semaphorin plexin signaling pathway involved in outflow tract morphogenesis | GO:2000764 | 1 | 0.611 | |
| regulation of stem cell differentiation | GO:2000736 | 50 | 0.610 | |
| forebrain development | GO:0030900 | 302 | 0.607 | |
| smoothened signaling pathway | GO:0007224 | 105 | 0.604 | |
| tendon cell differentiation | GO:0035990 | 4 | 0.596 | |
| positive regulation of neuron differentiation | GO:0045666 | 141 | 0.591 | |
| oligodendrocyte development | GO:0014003 | 20 | 0.587 | |
| skeletal system development | GO:0001501 | 356 | 0.574 | |
| cell fate specification involved in pattern specification | GO:0060573 | 11 | 0.574 | |
| auditory receptor cell fate specification | GO:0042667 | 1 | 0.572 | |
| amine metabolic process | GO:0009308 | 45 | 0.569 | |
| chondrocyte differentiation | GO:0002062 | 72 | 0.568 | |
| visceral serous pericardium development | GO:0061032 | 2 | 0.565 | |
| defense response to other organism | GO:0098542 | 197 | 0.564 | |
| glucose metabolic process | GO:0006006 | 92 | 0.563 | |
| pancreatic a cell differentiation | GO:0003310 | 7 | 0.553 | |
| positive regulation of keratinocyte proliferation | GO:0010838 | 4 | 0.550 | |
| central nervous system neuron differentiation | GO:0021953 | 162 | 0.549 | |
| regulation of ion transport | GO:0043269 | 215 | 0.545 | |
| cardiac chamber development | GO:0003205 | 108 | 0.543 | |
| cardiac ventricle development | GO:0003231 | 83 | 0.531 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.530 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.530 | |
| central nervous system neuron development | GO:0021954 | 67 | 0.527 | |
| circulatory system process | GO:0003013 | 197 | 0.521 | |
| collagen fibril organization | GO:0030199 | 32 | 0.518 | |
| embryonic placenta development | GO:0001892 | 98 | 0.513 | |
| negative regulation of peroxisome proliferator activated receptor signaling pathway | GO:0035359 | 3 | 0.513 | |
| negative regulation of nervous system development | GO:0051961 | 156 | 0.508 | |
| hindbrain development | GO:0030902 | 128 | 0.506 | |
| cell fate commitment | GO:0045165 | 210 | 0.506 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.505 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.502 | |
| regulation of voltage gated calcium channel activity | GO:1901385 | 4 | 0.499 | |
| sodium ion transport | GO:0006814 | 73 | 0.495 | |
| forebrain neuron development | GO:0021884 | 30 | 0.494 | |
| columnar cuboidal epithelial cell differentiation | GO:0002065 | 82 | 0.492 | Human |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.490 | |
| cellular response to peptide hormone stimulus | GO:0071375 | 92 | 0.488 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.486 | |
| forebrain generation of neurons | GO:0021872 | 63 | 0.484 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.476 | |
| response to endoplasmic reticulum stress | GO:0034976 | 53 | 0.476 | |
| insulin secretion | GO:0030073 | 89 | 0.475 | |
| gliogenesis | GO:0042063 | 141 | 0.473 | |
| cardiac right ventricle formation | GO:0003219 | 3 | 0.465 | |
| embryonic heart tube formation | GO:0003144 | 1 | 0.465 | |
| ventricular cardiac myofibril assembly | GO:0055005 | 3 | 0.453 | |
| limb morphogenesis | GO:0035108 | 149 | 0.450 | |
| transmission of nerve impulse | GO:0019226 | 76 | 0.449 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.446 | |
| stem cell development | GO:0048864 | 219 | 0.445 | |
| telencephalon development | GO:0021537 | 186 | 0.442 | |
| gland development | GO:0048732 | 330 | 0.440 | |
| transmembrane transport | GO:0055085 | 412 | 0.438 | |
| regulation of oxidative phosphorylation uncoupler activity | GO:2000275 | 3 | 0.434 | |
| regulation of secretion | GO:0051046 | 274 | 0.431 | |
| ensheathment of neurons | GO:0007272 | 76 | 0.427 | |
| neuron fate specification | GO:0048665 | 30 | 0.426 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.424 | |
| cell fate determination involved in pattern specification | GO:0060582 | 1 | 0.422 | |
| neuromuscular process | GO:0050905 | 99 | 0.419 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.417 | |
| mitral valve development | GO:0003174 | 4 | 0.417 | |
| positive regulation of stem cell differentiation | GO:2000738 | 23 | 0.404 | |
| limbic system development | GO:0021761 | 72 | 0.401 | |
| axonogenesis | GO:0007409 | 274 | 0.395 | |
| peptide transport | GO:0015833 | 133 | 0.391 | |
| cytokine production | GO:0001816 | 319 | 0.387 | |
| collagen biosynthetic process | GO:0032964 | 7 | 0.386 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.379 | |
| g protein coupled receptor signaling pathway | GO:0007186 | 243 | 0.378 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.377 | |
| cardiac chamber morphogenesis | GO:0003206 | 93 | 0.375 | |
| cartilage development | GO:0051216 | 140 | 0.375 | |
| embryonic heart tube development | GO:0035050 | 65 | 0.373 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.371 | |
| respiratory system development | GO:0060541 | 190 | 0.370 | |
| calcium mediated signaling | GO:0019722 | 46 | 0.360 | |
| regulation of peptide secretion | GO:0002791 | 77 | 0.356 | |
| limb development | GO:0060173 | 166 | 0.353 | |
| peptidyl tyrosine modification | GO:0018212 | 145 | 0.349 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.349 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.347 | |
| oxidation reduction process | GO:0055114 | 342 | 0.342 | |
| developmental programmed cell death | GO:0010623 | 41 | 0.341 | |
| cardiac muscle tissue morphogenesis | GO:0055008 | 44 | 0.341 | |
| multicellular organismal metabolic process | GO:0044236 | 28 | 0.338 | |
| second messenger mediated signaling | GO:0019932 | 73 | 0.335 | Human |
| protein processing | GO:0016485 | 163 | 0.335 | |
| spinal cord oligodendrocyte cell fate specification | GO:0021530 | 3 | 0.331 | |
| prostate gland development | GO:0030850 | 48 | 0.328 | |
| diencephalon development | GO:0021536 | 63 | 0.326 | |
| trophoblast giant cell differentiation | GO:0060707 | 15 | 0.325 | |
| heart morphogenesis | GO:0003007 | 178 | 0.321 | |
| muscle cell proliferation | GO:0033002 | 52 | 0.320 | |
| mitral valve morphogenesis | GO:0003183 | 4 | 0.317 | |
| cardiac muscle tissue development | GO:0048738 | 130 | 0.315 | |
| heart trabecula formation | GO:0060347 | 14 | 0.313 | |
| hippocampus development | GO:0021766 | 52 | 0.308 | |
| spleen development | GO:0048536 | 39 | 0.307 | |
| bmp signaling pathway | GO:0030509 | 93 | 0.307 | |
| carbohydrate homeostasis | GO:0033500 | 128 | 0.305 | |
| chemotaxis | GO:0006935 | 247 | 0.303 | |
| regulation of blood circulation | GO:1903522 | 93 | 0.302 | |
| cardiac ventricle morphogenesis | GO:0003208 | 50 | 0.299 | |
| paraxial mesodermal cell fate commitment | GO:0048343 | 2 | 0.296 | |
| positive regulation of secretion | GO:0051047 | 130 | 0.296 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.295 | |
| inner ear receptor cell differentiation | GO:0060113 | 61 | 0.295 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.294 | |
| regulation of cardiac muscle cell proliferation | GO:0060043 | 23 | 0.294 | |
| multicellular organismal response to stress | GO:0033555 | 62 | 0.292 | |
| outflow tract morphogenesis | GO:0003151 | 53 | 0.290 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.289 | |
| inorganic ion transmembrane transport | GO:0098660 | 234 | 0.289 | |
| embryonic skeletal system development | GO:0048706 | 120 | 0.288 | |
| blood circulation | GO:0008015 | 195 | 0.288 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.283 | |
| circadian rhythm | GO:0007623 | 114 | 0.282 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.282 | |
| regulation of jak stat cascade | GO:0046425 | 34 | 0.282 | |
| hormone metabolic process | GO:0042445 | 86 | 0.281 | |
| cellular response to transforming growth factor beta stimulus | GO:0071560 | 88 | 0.280 | |
| amacrine cell differentiation | GO:0035881 | 5 | 0.279 | |
| male gamete generation | GO:0048232 | 285 | 0.278 | |
| epithelial cell development | GO:0002064 | 159 | 0.278 | |
| canonical wnt signaling pathway | GO:0060070 | 130 | 0.278 | |
| oligodendrocyte differentiation | GO:0048709 | 53 | 0.277 | |
| regionalization | GO:0003002 | 337 | 0.275 | |
| negative regulation of sequence specific dna binding transcription factor activity | GO:0043433 | 40 | 0.275 | |
| regulation of organ morphogenesis | GO:2000027 | 144 | 0.274 | |
| glial cell fate commitment | GO:0021781 | 14 | 0.273 | |
| atrial cardiac muscle cell differentiation | GO:0055011 | 2 | 0.270 | |
| inner ear morphogenesis | GO:0042472 | 101 | 0.266 | |
| multicellular organismal signaling | GO:0035637 | 91 | 0.263 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.262 | |
| appendage development | GO:0048736 | 166 | 0.261 | |
| secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development | GO:0060528 | 4 | 0.260 | |
| regulation of lipid metabolic process | GO:0019216 | 118 | 0.260 | |
| apoptotic process involved in development | GO:1902742 | 28 | 0.257 | |
| phenol containing compound metabolic process | GO:0018958 | 60 | 0.256 | |
| embryonic appendage morphogenesis | GO:0035113 | 126 | 0.256 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.256 | |
| carbon catabolite repression of transcription from rna polymerase ii promoter | GO:0000437 | 1 | 0.255 | |
| muscle cell apoptotic process | GO:0010657 | 18 | 0.253 | |
| regulation of cellular carbohydrate metabolic process | GO:0010675 | 75 | 0.251 | |
| multicellular organism growth | GO:0035264 | 161 | 0.248 | |
| neuroendocrine cell differentiation | GO:0061101 | 7 | 0.248 | |
| negative regulation of cell development | GO:0010721 | 169 | 0.248 | |
| generation of precursor metabolites and energy | GO:0006091 | 103 | 0.247 | |
| regulation of smoothened signaling pathway | GO:0008589 | 58 | 0.246 | |
| glial cell differentiation | GO:0010001 | 131 | 0.246 | |
| cell fate specification | GO:0001708 | 72 | 0.245 | |
| determination of left right symmetry | GO:0007368 | 80 | 0.244 | Zebrafish |
| neuron fate determination | GO:0048664 | 9 | 0.243 | |
| mesenchymal cell development | GO:0014031 | 93 | 0.242 | |
| kidney epithelium development | GO:0072073 | 121 | 0.241 | |
| respiratory tube development | GO:0030323 | 167 | 0.241 | |
| regulation of glucose metabolic process | GO:0010906 | 60 | 0.240 | |
| cellular component assembly involved in morphogenesis | GO:0010927 | 139 | 0.239 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.239 | |
| cation transport | GO:0006812 | 399 | 0.238 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.237 | |
| regulation of peptide transport | GO:0090087 | 91 | 0.234 | |
| germ cell development | GO:0007281 | 185 | 0.232 | |
| positive regulation of insulin secretion | GO:0032024 | 26 | 0.232 | |
| fear response | GO:0042596 | 33 | 0.232 | |
| spinal cord patterning | GO:0021511 | 25 | 0.231 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.231 | |
| ventral midline development | GO:0007418 | 4 | 0.229 | |
| establishment or maintenance of epithelial cell apical basal polarity | GO:0045197 | 14 | 0.229 | |
| regulation of cardiac muscle tissue growth | GO:0055021 | 26 | 0.228 | |
| regulation of translation | GO:0006417 | 71 | 0.227 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.225 | |
| positive regulation of hormone secretion | GO:0046887 | 38 | 0.224 | |
| camera type eye development | GO:0043010 | 266 | 0.223 | |
| mitochondrion distribution | GO:0048311 | 4 | 0.222 | |
| oligodendrocyte cell fate commitment | GO:0021779 | 5 | 0.222 | |
| renal system development | GO:0072001 | 225 | 0.221 | |
| fat cell differentiation | GO:0045444 | 160 | 0.221 | |
| embryonic limb morphogenesis | GO:0030326 | 126 | 0.221 | |
| positive regulation of glial cell differentiation | GO:0045687 | 21 | 0.219 | |
| spinal cord association neuron differentiation | GO:0021527 | 14 | 0.218 | |
| apoptotic process involved in heart morphogenesis | GO:0003278 | 5 | 0.217 | |
| middle ear morphogenesis | GO:0042474 | 23 | 0.216 | |
| pericardium development | GO:0060039 | 16 | 0.215 | |
| sperm capacitation | GO:0048240 | 17 | 0.215 | |
| response to peptide | GO:1901652 | 136 | 0.215 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.214 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.214 | |
| type b pancreatic cell differentiation | GO:0003309 | 13 | 0.212 | Human |
| positive regulation of dendritic spine morphogenesis | GO:0061003 | 8 | 0.211 | |
| epithelial cell fate commitment | GO:0072148 | 13 | 0.211 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.211 | |
| digestive tract development | GO:0048565 | 190 | 0.211 | |
| intrinsic apoptotic signaling pathway | GO:0097193 | 132 | 0.210 | |
| regulation of sequence specific dna binding transcription factor activity | GO:0051090 | 106 | 0.208 | |
| response to drug | GO:0042493 | 75 | 0.206 | |
| cardiac muscle cell apoptotic process | GO:0010659 | 10 | 0.206 | |
| cerebellum development | GO:0021549 | 77 | 0.205 | |
| cellular response to peptide | GO:1901653 | 92 | 0.205 | |
| positive regulation of synaptic plasticity | GO:0031915 | 4 | 0.202 | |
| forebrain regionalization | GO:0021871 | 25 | 0.202 | |
| aortic valve morphogenesis | GO:0003180 | 4 | 0.202 | |
| cerebral cortex development | GO:0021987 | 86 | 0.200 | |
| positive regulation of transcription via serum response element binding | GO:0010735 | 1 | 0.200 | |
| ossification | GO:0001503 | 216 | 0.198 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.198 | |
| cardiac muscle cell differentiation | GO:0055007 | 69 | 0.198 | |
| columnar cuboidal epithelial cell development | GO:0002066 | 29 | 0.198 | |
| extracellular structure organization | GO:0043062 | 148 | 0.197 | |
| response to peptide hormone | GO:0043434 | 127 | 0.197 | |
| digestive system development | GO:0055123 | 200 | 0.196 | |
| regulation of transcription from rna polymerase ii promoter involved in ventral spinal cord interneuron specification | GO:0021913 | 4 | 0.194 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.194 | |
| paraxial mesodermal cell differentiation | GO:0048342 | 2 | 0.194 | |
| regulation of glial cell differentiation | GO:0045685 | 41 | 0.194 | |
| myeloid leukocyte differentiation | GO:0002573 | 119 | 0.192 | |
| mesenchymal cell differentiation | GO:0048762 | 107 | 0.191 | |
| regulation of stem cell maintenance | GO:2000036 | 17 | 0.190 | |
| bone morphogenesis | GO:0060349 | 78 | 0.190 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.188 | |
| regulation of binding | GO:0051098 | 111 | 0.188 | |
| lung development | GO:0030324 | 164 | 0.188 | |
| b cell activation | GO:0042113 | 161 | 0.187 | |
| immune effector process | GO:0002252 | 321 | 0.187 | |
| hematopoietic stem cell differentiation | GO:0060218 | 8 | 0.187 | |
| embryonic heart tube morphogenesis | GO:0003143 | 51 | 0.186 | |
| cardiocyte differentiation | GO:0035051 | 87 | 0.185 | |
| regulation of cell morphogenesis involved in differentiation | GO:0010769 | 151 | 0.185 | |
| negative regulation of glial cell differentiation | GO:0045686 | 21 | 0.184 | |
| response to monosaccharide | GO:0034284 | 67 | 0.184 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.183 | |
| ventral spinal cord interneuron specification | GO:0021521 | 11 | 0.181 | |
| negative regulation of synapse maturation | GO:2000297 | 2 | 0.180 | |
| floor plate development | GO:0033504 | 7 | 0.180 | |
| cell maturation | GO:0048469 | 127 | 0.179 | |
| inflammatory response | GO:0006954 | 244 | 0.179 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.179 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.176 | |
| organelle assembly | GO:0070925 | 177 | 0.175 | |
| regulation of cell cycle arrest | GO:0071156 | 12 | 0.175 | |
| neuroblast proliferation | GO:0007405 | 49 | 0.174 | |
| cell cycle arrest | GO:0007050 | 37 | 0.172 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.172 | |
| neural tube patterning | GO:0021532 | 43 | 0.167 | |
| somitogenesis | GO:0001756 | 69 | 0.166 | |
| positive regulation of blood circulation | GO:1903524 | 22 | 0.166 | |
| cell growth | GO:0016049 | 130 | 0.165 | |
| somatotropin secreting cell differentiation | GO:0060126 | 4 | 0.165 | |
| negative regulation of cell cycle | GO:0045786 | 123 | 0.164 | |
| deltoid tuberosity development | GO:0035993 | 3 | 0.164 | |
| b cell differentiation | GO:0030183 | 78 | 0.163 | |
| auditory receptor cell differentiation | GO:0042491 | 37 | 0.163 | |
| axon guidance | GO:0007411 | 141 | 0.163 | |
| cellular homeostasis | GO:0019725 | 240 | 0.163 | |
| neuron projection guidance | GO:0097485 | 141 | 0.163 | |
| positive regulation of exit from mitosis | GO:0031536 | 1 | 0.162 | |
| replacement ossification | GO:0036075 | 26 | 0.161 | |
| spinal cord oligodendrocyte cell differentiation | GO:0021529 | 3 | 0.161 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.160 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.159 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.159 | |
| regulation of embryonic development | GO:0045995 | 71 | 0.159 | |
| striated muscle cell proliferation | GO:0014855 | 39 | 0.159 | |
| epithelial cell morphogenesis | GO:0003382 | 41 | 0.158 | |
| endochondral bone morphogenesis | GO:0060350 | 50 | 0.158 | |
| digestion | GO:0007586 | 40 | 0.158 | |
| regulation of circadian rhythm | GO:0042752 | 58 | 0.157 | |
| prostate gland morphogenesis | GO:0060512 | 32 | 0.156 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.154 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.153 | |
| cellular response to monosaccharide stimulus | GO:0071326 | 47 | 0.153 | |
| renal capsule morphogenesis | GO:0072128 | 1 | 0.153 | |
| spinal cord motor neuron differentiation | GO:0021522 | 35 | 0.152 | |
| cellular response to cytokine stimulus | GO:0071345 | 189 | 0.152 | |
| regulation of ion transmembrane transport | GO:0034765 | 119 | 0.151 | |
| regulation of carbohydrate metabolic process | GO:0006109 | 75 | 0.150 | |
| regulation of muscle cell apoptotic process | GO:0010660 | 17 | 0.147 | |
| regulation of neuron projection development | GO:0010975 | 169 | 0.147 | |
| stem cell proliferation | GO:0072089 | 117 | 0.147 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.146 | |
| cell differentiation involved in embryonic placenta development | GO:0060706 | 26 | 0.145 | |
| positive regulation of neural precursor cell proliferation | GO:2000179 | 42 | 0.145 | |
| signal transduction in absence of ligand | GO:0038034 | 55 | 0.145 | |
| pallium development | GO:0021543 | 120 | 0.144 | |
| regulation of transcription involved in cell fate commitment | GO:0060850 | 15 | 0.143 | |
| forebrain neuron differentiation | GO:0021879 | 52 | 0.143 | |
| blood vessel remodeling | GO:0001974 | 33 | 0.143 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.143 | |
| mesonephros development | GO:0001823 | 97 | 0.141 | |
| enteroendocrine cell differentiation | GO:0035883 | 16 | 0.140 | Human |
| positive regulation of stem cell proliferation | GO:2000648 | 59 | 0.139 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.139 | |
| mechanoreceptor differentiation | GO:0042490 | 67 | 0.138 | |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 0 | 0.137 | |
| erythrocyte maturation | GO:0043249 | 6 | 0.137 | |
| platelet morphogenesis | GO:0036344 | 13 | 0.137 | |
| venous blood vessel development | GO:0060841 | 13 | 0.137 | |
| phospholipid metabolic process | GO:0006644 | 87 | 0.137 | |
| type b pancreatic cell apoptotic process | GO:0097050 | 6 | 0.136 | |
| apoptotic process involved in morphogenesis | GO:0060561 | 25 | 0.136 | |
| atrial cardiac muscle cell development | GO:0055014 | 2 | 0.135 | |
| cardiac muscle contraction | GO:0060048 | 32 | 0.135 | |
| apoptotic process involved in outflow tract morphogenesis | GO:0003275 | 2 | 0.135 | |
| carbon catabolite activation of transcription | GO:0045991 | 4 | 0.135 | |
| ventral spinal cord development | GO:0021517 | 48 | 0.135 | |
| jak stat cascade | GO:0007259 | 42 | 0.134 | |
| spinal cord dorsal ventral patterning | GO:0021513 | 23 | 0.134 | |
| ventral spinal cord interneuron differentiation | GO:0021514 | 16 | 0.134 | |
| organophosphate biosynthetic process | GO:0090407 | 122 | 0.134 | |
| response to camp | GO:0051591 | 14 | 0.133 | |
| response to transforming growth factor beta | GO:0071559 | 88 | 0.133 | |
| spinal cord motor neuron cell fate specification | GO:0021520 | 13 | 0.133 | |
| negative regulation of jak stat cascade | GO:0046426 | 7 | 0.133 | |
| regulation of muscle system process | GO:0090257 | 80 | 0.131 | |
| pituitary gland development | GO:0021983 | 38 | 0.131 | |
| positive regulation of ion transmembrane transporter activity | GO:0032414 | 15 | 0.130 | |
| positive regulation of semaphorin plexin signaling pathway | GO:2001262 | 1 | 0.129 | |
| forelimb morphogenesis | GO:0035136 | 40 | 0.129 | |
| regulation of endoplasmic reticulum stress induced intrinsic apoptotic signaling pathway | GO:1902235 | 11 | 0.128 | |
| learning or memory | GO:0007611 | 148 | 0.128 | |
| urogenital system development | GO:0001655 | 261 | 0.127 | |
| epidermis development | GO:0008544 | 187 | 0.126 | |
| central nervous system myelination | GO:0022010 | 12 | 0.126 | |
| divalent inorganic cation transport | GO:0072511 | 178 | 0.126 | |
| negative regulation of oxidative phosphorylation uncoupler activity | GO:2000276 | 2 | 0.126 | |
| kidney morphogenesis | GO:0060993 | 83 | 0.125 | |
| hair cell differentiation | GO:0035315 | 40 | 0.125 | |
| leukocyte migration | GO:0050900 | 124 | 0.125 | |
| neural crest cell development | GO:0014032 | 48 | 0.124 | |
| spermatogenesis | GO:0007283 | 284 | 0.124 | |
| erythrocyte differentiation | GO:0030218 | 88 | 0.123 | |
| cation homeostasis | GO:0055080 | 212 | 0.123 | |
| embryonic epithelial tube formation | GO:0001838 | 130 | 0.122 | |
| calcium ion transmembrane transport | GO:0070588 | 85 | 0.122 | |
| type ii pneumocyte differentiation | GO:0060510 | 7 | 0.122 | |
| protein ubiquitination | GO:0016567 | 171 | 0.122 | |
| heart contraction | GO:0060047 | 93 | 0.121 | |
| head morphogenesis | GO:0060323 | 34 | 0.121 | |
| sclerotome development | GO:0061056 | 4 | 0.121 | |
| cerebellar granule cell precursor proliferation | GO:0021930 | 10 | 0.120 | |
| endocardial cushion to mesenchymal transition | GO:0090500 | 5 | 0.120 | |
| ear morphogenesis | GO:0042471 | 118 | 0.119 | |
| regulation of myeloid cell differentiation | GO:0045637 | 96 | 0.119 | |
| glandular epithelial cell development | GO:0002068 | 15 | 0.118 | |
| pattern specification involved in metanephros development | GO:0072268 | 4 | 0.118 | |
| type b pancreatic cell development | GO:0003323 | 10 | 0.116 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.116 | |
| regulation of body fluid levels | GO:0050878 | 162 | 0.115 | |
| regulation of axon extension | GO:0030516 | 43 | 0.114 | |
| tube formation | GO:0035148 | 140 | 0.114 | |
| regulation of neural precursor cell proliferation | GO:2000177 | 70 | 0.113 | |
| peptidyl tyrosine phosphorylation | GO:0018108 | 143 | 0.112 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.112 | |
| mesenchyme development | GO:0060485 | 152 | 0.112 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.112 | |
| alcohol metabolic process | GO:0006066 | 116 | 0.111 | |
| carbon catabolite activation of transcription from rna polymerase ii promoter | GO:0000436 | 4 | 0.111 | |
| positive regulation of cell cycle | GO:0045787 | 92 | 0.110 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.110 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.110 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.110 | |
| hormone secretion | GO:0046879 | 128 | 0.110 | |
| notch signaling pathway | GO:0007219 | 71 | 0.109 | |
| cellular response to carbohydrate stimulus | GO:0071322 | 50 | 0.108 | |
| regulation of calcium mediated signaling | GO:0050848 | 19 | 0.108 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.107 | |
| dentate gyrus development | GO:0021542 | 14 | 0.107 | |
| ventricular cardiac muscle cell differentiation | GO:0055012 | 17 | 0.107 | |
| regulation of mitotic cell cycle | GO:0007346 | 126 | 0.106 | |
| regulation of cell division | GO:0051302 | 76 | 0.106 | |
| regulation of cardioblast differentiation | GO:0051890 | 3 | 0.106 | |
| detection of glucose | GO:0051594 | 1 | 0.105 | |
| granulosa cell differentiation | GO:0060014 | 1 | 0.105 | |
| cerebral cortex radial glia guided migration | GO:0021801 | 17 | 0.105 | |
| lactation | GO:0007595 | 25 | 0.105 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.105 | |
| regulation of epithelial to mesenchymal transition | GO:0010717 | 22 | 0.105 | |
| embryonic skeletal system morphogenesis | GO:0048704 | 91 | 0.104 | |
| fertilization | GO:0009566 | 127 | 0.104 | |
| leydig cell differentiation | GO:0033327 | 10 | 0.104 | |
| regulation of striated muscle cell apoptotic process | GO:0010662 | 11 | 0.104 | |
| carbon catabolite regulation of transcription from rna polymerase ii promoter | GO:0000429 | 4 | 0.103 | |
| metanephric capsule specification | GO:0072267 | 1 | 0.103 | |
| positive regulation of transcription from rna polymerase ii promoter by glucose | GO:0000432 | 3 | 0.103 | |
| response to purine containing compound | GO:0014074 | 28 | 0.103 | |
| response to growth factor | GO:0070848 | 198 | 0.102 | |
| chromatin modification | GO:0016568 | 187 | 0.102 | |
| intracellular distribution of mitochondria | GO:0048312 | 1 | 0.102 | |
| glycerolipid metabolic process | GO:0046486 | 122 | 0.101 | |
| lung morphogenesis | GO:0060425 | 50 | 0.101 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.101 | |
| positive regulation of cytokine production | GO:0001819 | 174 | 0.101 | |
| cerebellum morphogenesis | GO:0021587 | 42 | 0.101 | |
| response to amino acid | GO:0043200 | 37 | 0.100 | |
| axon ensheathment | GO:0008366 | 76 | 0.100 | |
| adult behavior | GO:0030534 | 135 | 0.100 | |
| regulation of ion transmembrane transporter activity | GO:0032412 | 54 | 0.099 | |
| regulation of cell cycle process | GO:0010564 | 160 | 0.099 | |
| b cell activation involved in immune response | GO:0002312 | 50 | 0.099 | |
| tissue remodeling | GO:0048771 | 102 | 0.099 | |
| regulation of erythrocyte differentiation | GO:0045646 | 23 | 0.098 | |
| neural crest cell differentiation | GO:0014033 | 54 | 0.098 | |
| skin development | GO:0043588 | 220 | 0.097 | |
| clara cell differentiation | GO:0060486 | 4 | 0.097 | |
| muscle tissue morphogenesis | GO:0060415 | 53 | 0.096 | |
| pharynx development | GO:0060465 | 1 | 0.095 | |
| regulation of osteoblast differentiation | GO:0045667 | 67 | 0.095 | |
| cardiac neural crest cell development involved in heart development | GO:0061308 | 7 | 0.095 | |
| dendrite development | GO:0016358 | 115 | 0.095 | |
| regulation of systemic arterial blood pressure mediated by a chemical signal | GO:0003044 | 33 | 0.095 | |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.095 | |
| cardiac pacemaker cell fate commitment | GO:0060927 | 1 | 0.094 | |
| tissue homeostasis | GO:0001894 | 115 | 0.094 | |
| carbon catabolite repression of transcription | GO:0045013 | 1 | 0.094 | |
| trophectodermal cell differentiation | GO:0001829 | 21 | 0.093 | |
| cardiac muscle cell development | GO:0055013 | 39 | 0.093 | |
| glial cell development | GO:0021782 | 54 | 0.093 | |
| face morphogenesis | GO:0060325 | 29 | 0.093 | |
| cation transmembrane transport | GO:0098655 | 266 | 0.093 | |
| carbon catabolite regulation of transcription | GO:0045990 | 4 | 0.093 | |
| cell proliferation in external granule layer | GO:0021924 | 10 | 0.092 | |
| positive regulation of secretion by cell | GO:1903532 | 114 | 0.092 | |
| positive regulation of sequence specific dna binding transcription factor activity | GO:0051091 | 68 | 0.091 | |
| energy derivation by oxidation of organic compounds | GO:0015980 | 77 | 0.090 | |
| cell proliferation in forebrain | GO:0021846 | 30 | 0.090 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.090 | |
| organ growth | GO:0035265 | 117 | 0.089 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.089 | |
| nephron epithelium development | GO:0072009 | 92 | 0.089 | |
